Life sciences companies have long been outside the scope of US national security regulations and benefited from significant exemptions under US privacy laws. ...more
4/15/2025
/ CFIUS ,
China ,
Clinical Trials ,
Cybersecurity Information Sharing Act (CISA) ,
Data Privacy ,
Data Protection ,
Department of Justice (DOJ) ,
Foreign Investment ,
Life Sciences ,
National Security ,
Personal Data ,
Regulatory Requirements ,
Sensitive Personal Information
On April 8, 2025, a sweeping rule issued by the US Department of Justice (DOJ) will take effect. The rule imposes restrictions—and in some cases, outright prohibitions—on US companies in connection with certain types of data...more
4/7/2025
/ China ,
Corporate Counsel ,
Cuba ,
Cybersecurity ,
Cybersecurity Information Sharing Act (CISA) ,
Data Privacy ,
Data Security ,
Department of Justice (DOJ) ,
Foreign Investment ,
International Data Transfers ,
Iran ,
New Rules ,
North Korea ,
Personal Data ,
Personal Information ,
Regulatory Requirements ,
Russia ,
Sensitive Personal Information ,
Third-Party Risk ,
Third-Party Service Provider ,
Venezuela